Review





Similar Products

tgf β1  (MedChemExpress)
94
MedChemExpress tgf β1
Tgf β1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf β1/product/MedChemExpress
Average 94 stars, based on 1 article reviews
tgf β1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
human tgf β1  (Sino Biological)
93
Sino Biological human tgf β1
Human Tgf β1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tgf β1/product/Sino Biological
Average 93 stars, based on 1 article reviews
human tgf β1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
growth factor β1  (MedChemExpress)
94
MedChemExpress growth factor β1
A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).
Growth Factor β1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/growth factor β1/product/MedChemExpress
Average 94 stars, based on 1 article reviews
growth factor β1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
tgf b  (MedChemExpress)
94
MedChemExpress tgf b
A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).
Tgf B, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf b/product/MedChemExpress
Average 94 stars, based on 1 article reviews
tgf b - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti tgf β1 lap  (Proteintech)
96
Proteintech anti tgf β1 lap
A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).
Anti Tgf β1 Lap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti tgf β1 lap/product/Proteintech
Average 96 stars, based on 1 article reviews
anti tgf β1 lap - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
tgf β  (MedChemExpress)
94
MedChemExpress tgf β
A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).
Tgf β, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf β/product/MedChemExpress
Average 94 stars, based on 1 article reviews
tgf β - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
hy p78668 medchemexprss  (MedChemExpress)
93
MedChemExpress hy p78668 medchemexprss
A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).
Hy P78668 Medchemexprss, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hy p78668 medchemexprss/product/MedChemExpress
Average 93 stars, based on 1 article reviews
hy p78668 medchemexprss - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
recombinant proteins tgf beta 1 protein  (Sino Biological)
93
Sino Biological recombinant proteins tgf beta 1 protein
A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).
Recombinant Proteins Tgf Beta 1 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant proteins tgf beta 1 protein/product/Sino Biological
Average 93 stars, based on 1 article reviews
recombinant proteins tgf beta 1 protein - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).

Journal: Cell Death & Disease

Article Title: Targeting the SMAD3/CISD2 axis suppresses bladder cancer progression by promoting ferroptosis in mesenchymal-like bladder cancer cells

doi: 10.1038/s41419-025-08339-9

Figure Lengend Snippet: A, B Relative expression levels of EMT markers VIM and CDH2 across TNM stages (T1–T4) and clinical stages (Stage I–IV) in bladder cancer (BCa) from the TCGA dataset. C–E IHC staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC versus NMIBC tissues. F–H IF staining of EMT markers E-cadherin, Vimentin, and N-cadherin in MIBC compared to NMIBC tissues. I–K Kaplan-Meier survival curves showing that the expression of CDH1, VIM, and CDH2 are associated with overall survival (OS) in bladder cancer patients. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).

Article Snippet: Chemical reagents used in this study included: recombinant human transforming growth factor β1 (TGF-β1, HY- P78168 ), ferroptosis inducers Erastin (HY-15763) and RSL3 (HY-100218A), ferroptosis inhibitor Ferrostatin-1 (Fer-1, HY-100579), and iron chelator Deferoxamine mesylate (DFO, HY-B0988), all purchased from MedChemExpress (MCE) with purity ≥98%.

Techniques: Expressing, Immunohistochemistry, Staining

A , B Western blot confirming TGF-β1-induced suppression of epithelial markers (E-cadherin) and upregulation of mesenchymal markers (Vimentin, N-cadherin). C CCK-8 assay demonstrating the effect of different concentrations of TGF-β1 on cell viability. D Transwell migration and invasion assays demonstrated changes in migratory and invasive abilities of mesenchymal-like bladder cancer cells. E , F Immunofluorescence staining of EMT markers (E-cadherin, Vimentin) in TGF-β1-treated cells. G , H RT-qPCR profiling of TGF-β1-modulated ferroptosis-related genes (GPX4, SLC7A11, FTH1, FACL4) in cells. I Western blot analysis of ferroptosis suppressor proteins (GPX4, SLC7A11) in TGF-β1-treated cells. J LPO assay showing elevated LPO levels in TGF-β1-exposed cells. K GSH assay revealing TGF-β1-induced GSH depletion in cells. L Schematic summary of TGF-β1-driven EMT promoting redox imbalance and ferroptosis sensitivity in bladder cancer cells. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).

Journal: Cell Death & Disease

Article Title: Targeting the SMAD3/CISD2 axis suppresses bladder cancer progression by promoting ferroptosis in mesenchymal-like bladder cancer cells

doi: 10.1038/s41419-025-08339-9

Figure Lengend Snippet: A , B Western blot confirming TGF-β1-induced suppression of epithelial markers (E-cadherin) and upregulation of mesenchymal markers (Vimentin, N-cadherin). C CCK-8 assay demonstrating the effect of different concentrations of TGF-β1 on cell viability. D Transwell migration and invasion assays demonstrated changes in migratory and invasive abilities of mesenchymal-like bladder cancer cells. E , F Immunofluorescence staining of EMT markers (E-cadherin, Vimentin) in TGF-β1-treated cells. G , H RT-qPCR profiling of TGF-β1-modulated ferroptosis-related genes (GPX4, SLC7A11, FTH1, FACL4) in cells. I Western blot analysis of ferroptosis suppressor proteins (GPX4, SLC7A11) in TGF-β1-treated cells. J LPO assay showing elevated LPO levels in TGF-β1-exposed cells. K GSH assay revealing TGF-β1-induced GSH depletion in cells. L Schematic summary of TGF-β1-driven EMT promoting redox imbalance and ferroptosis sensitivity in bladder cancer cells. Data are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant ( p > 0.05).

Article Snippet: Chemical reagents used in this study included: recombinant human transforming growth factor β1 (TGF-β1, HY- P78168 ), ferroptosis inducers Erastin (HY-15763) and RSL3 (HY-100218A), ferroptosis inhibitor Ferrostatin-1 (Fer-1, HY-100579), and iron chelator Deferoxamine mesylate (DFO, HY-B0988), all purchased from MedChemExpress (MCE) with purity ≥98%.

Techniques: Western Blot, CCK-8 Assay, Migration, Immunofluorescence, Staining, Quantitative RT-PCR, GSH Assay